Effects of siRNA against survivin combined with tamoxifen on the proliferation and apoptosis in breast cancer MCF-7 cell

GUAN Hai-tao,XUE Xing-huan,WANG Xi-jing,XUE Feng-jie,LIU Xiao-xu,DAI Zhi-jun,SONG Ling-qin,MIN Wei-li
DOI: https://doi.org/10.3969/j.issn.1672-4992.2007.04.011
2007-01-01
Journal of Modern Oncology
Abstract:Objective: To investigate the effects of siRNA against survivin combined with tamoxifen on the proliferation and apoptosis in breast cancer MCF-7 cell. Methods: Constructed a siRNA eukaryotic expression vector against survivin and transfected it into MCF-7 cell with lipofectamineTM 2000. The effect of siRNA against survivin combined with tamoxifen on the proliferation of MCF-7 cell was detected by MTT assay and that of inducing MCF-7 cell apoptosis was detected by flow cytometry. Results: Both siRNA against survivin and tamoxifen can suppress the proliferation of MCF-7 cell and induce its apoptosis in a certain degree, and siRNA against survivin combined with tamoxifen enhanced the both effects significantly(P<0.05). Conclusion: Blocking the expression of survivin with siRNA can significantly enhance the sensitivity of MCF-7 cell to tamoxifen. That suggested that RNA interference technology against survivin has important potential value in the endocrine therapy of breast cancer.
What problem does this paper attempt to address?